President-elect Donald J. Trump’s selections to run the nation’s health agencies are alarming infectious disease experts.

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

A new Biden administration proposal could allow millions of Americans with obesity to access weight-loss drugs like Wegovy ...

The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...

Last, the administration's proposal also tries to shore up guardrails for the use of AI in health care with edits to existing ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...

A proposal floated Tuesday by outgoing President Joe Biden to require Medicare and Medicaid to offer coverage for prescriptions of popular but expensive injectable weight loss drugs had the tentative ...

The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...

The Biden administration is looking to extend Medicare and Medicaid coverage to include obesity drugs like Wegovy and Zepbound. Weight loss drugs are now excluded from mandatory coverage.